PetMed Express, Inc. (PETS) |
| 1.27 0.01 (0.79%) 10-13 16:00 |
| Open: | 1.28 |
| High: | 1.3 |
| Low: | 1.27 |
| Volume: | 87,723 |
| Market Cap: | 27(M) |
| PE Ratio: | -0.97 |
| Exchange: | NASDAQ Global Select |
| Industry: | Specialty Retail |
| Sector: | Consumer Cyclical |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 1.75 |
| Resistance 1: | 1.56 |
| Pivot price: | 1.37 |
| Support 1: | 1.26 |
| Support 2: | 1.05 |
| 52w High: | 4.1 |
| 52w Low: | 1.26 |
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
| EPS | -1.380 |
| Book Value | 1.090 |
| PEG Ratio | 2.32 |
| Gross Profit | 2.175 |
| Profit Margin (%) | -17.34 |
| Operating Margin (%) | -15.19 |
| Return on Assets (ttm) | -20.0 |
| Return on Equity (ttm) | -78.6 |
Sat, 03 Oct 2026
PetMed Express, Inc. (PETS) stock price, news, quote and history - Yahoo Finance UK
Tue, 29 Sep 2026
A 250,000-share restricted award goes to PetMed Express (PETS) CEO. Another grant hinges on returns. - Stock Titan
Tue, 29 Sep 2026
Jeffrey Allen Willard, CEO and president of PetMed Express (PETS), is named in an initial ownership report. - Stock Titan
Mon, 28 Sep 2026
PetMed names Jeffrey Allen Willard as CEO with equity grants under amended plan - TradingView
Thu, 13 Aug 2026
PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Narrowing Losses and Strategic ... - Yahoo Finance
Thu, 13 Aug 2026
Full Transcript: PetMed Express Q1 2027 Earnings Call - Benzinga
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |